Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Acute Respiratory and Critical Conditions
Pharmaceutical
Biopharma
Date founded
2020
Funding rounds raised
Total raised
$50M
from 3 investors over 3 rounds
E
Enalare Therapeutics Inc. raised $50M on September 27, 2022
Investors: Biomedical Advanced Research and Development Authority (BARDA)
E
Enalare Therapeutics Inc. raised $13M on August 9, 2022
Investors: Eagle Pharmaceuticals, Inc.
E
Enalare Therapeutics Inc. raised undisclosed on July 1, 2022
Investors: The National Institute on Drug Abuse (NIDA)